Holen Sie sich die Stockscreener-App
0.785
1.53%
-0.0124
Schlusskurs vom Vortag:
$0.7974
Offen:
$0.8
24-Stunden-Volumen:
160.34K
Relative Volume:
0.57
Marktkapitalisierung:
$60.33M
Einnahmen:
$9.53M
Nettoeinkommen (Verlust:
$-44.61M
KGV:
-0.8626
EPS:
-0.91
Netto-Cashflow:
$-38.32M
1W Leistung:
-8.48%
1M Leistung:
+6.12%
6M Leistung:
-1.85%
1J Leistung:
-29.89%
1-Tages-Spanne:
$0.7837
$0.80
1-Wochen-Bereich:
$0.72
$0.96
52-Wochen-Spanne:
$0.5406
$1.9891
Cue Biopharma Inc Stock (CUE) Company Profile
Firmenname
Cue Biopharma Inc
Sektor
Branche
Telefon
617-949-2680
Adresse
40 GUEST STREET, BOSTON, MA
Vergleichen Sie CUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.7851 | 61.28M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.18 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
475.96 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.00 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.96 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.44 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-11-21 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-03 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-24 | Eingeleitet | Berenberg | Buy |
| 2020-04-09 | Eingeleitet | Stifel | Buy |
| 2020-01-28 | Eingeleitet | BTIG Research | Buy |
| 2020-01-22 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Cue Biopharma Inc Aktie (CUE) Neueste Nachrichten
Will Cue Biopharma Inc. stock recover after recent dropJuly 2025 Intraday Action & AI Forecasted Entry/Exit Points - newser.com
Is Cue Biopharma Inc. reversing from oversold territoryQuarterly Profit Report & AI Based Buy/Sell Signal Reports - newser.com
What dividend safety score for Cue Biopharma Inc. stockPortfolio Return Report & Free Technical Confirmation Trade Alerts - newser.com
Is Cue Biopharma Inc. stock a top momentum play2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Using portfolio simulators with Cue Biopharma Inc. includedSwing Trade & Reliable Intraday Trade Plans - newser.com
How Cue Biopharma Inc. (1UC) stock stacks up against competitorsQuarterly Investment Review & Advanced Technical Signal Analysis - newser.com
Analyzing net buyer seller activity in Cue Biopharma Inc.Weekly Trade Review & Accurate Intraday Trade Tips - newser.com
Is Cue Biopharma Inc. (1UC) stock undervalued after correctionTrade Signal Summary & Free Real-Time Market Sentiment Alerts - newser.com
What recovery options are there for Cue Biopharma Inc.Buy Signal & Momentum Based Trading Ideas - newser.com
Published on: 2025-10-12 06:58:11 - newser.com
What drives Cue Biopharma Inc stock priceValue Stock Picks & Low Cost Trading Ideas - earlytimes.in
Cue Biopharma stock adds to gains after Nobel Prize validates CUE-401 approach - Investing.com Nigeria
Is Cue Biopharma (NASDAQ:CUE) Using Debt In A Risky Way? - simplywall.st
Tick level data insight on Cue Biopharma Inc. volatility2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Is it time to cut losses on Cue Biopharma Inc.Trade Risk Assessment & Daily Chart Pattern Signals - newser.com
Cue Biopharma, Inc. (NASDAQ:CUE) Sees Significant Drop in Short Interest - MarketBeat
Will Cue Biopharma Inc. stock reach all time highs in 2025July 2025 Intraday Action & Safe Entry Point Alerts - newser.com
Reversal indicators forming on Cue Biopharma Inc. stockAnalyst Upgrade & Growth Oriented Trading Recommendations - newser.com
Will breakout in Cue Biopharma Inc. lead to full recoveryVolume Spike & Daily Growth Stock Tips - newser.com
Developing predictive dashboards with Cue Biopharma Inc. dataMarket Sentiment Report & Free Growth Oriented Trading Recommendations - newser.com
Market reaction to Cue Biopharma Inc.’s recent news2025 Top Decliners & Daily Profit Focused Screening - newser.com
Cue Biopharma names Usman Azam as new CEO and president - The Pharma Letter
Building trade automation scripts for Cue Biopharma Inc.2025 Bull vs Bear & Consistent Income Trade Recommendations - newser.com
Cue Biopharma names Usman Azam as new CEO, shifts focus to autoimmune disease - Investing.com Nigeria
Cue Biopharma Appoints Usman “Oz” Azam, M.D., as CEO - citybiz
Finanzdaten der Cue Biopharma Inc-Aktie (CUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.83%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):